Search
trifarotene (Aklief)
Indications:
- acne (FDA-approved for patients >= 9 year)
Dosage:
- applied once daily
- 0.05 mg/mL Topical Cream [Aklief]
provided in a 45-gram pump
Adverse effects:
- application-site irritation
- application-site pruritus
- sunburn
Mechanism of action:
- topical retinoid
- selectively targets retinoic acid receptor gamma (RAR-gamma)
General
retinoid
topical agent
Database Correlations
PUBCHEM cid=11518241
References
- RxNorm
- Brooks M
Cite this: FDA OKs Trifarotene, First New Retinoid Acne Cream in 20 Years.
Medscape - Oct 04, 2019.
https://www.medscape.com/viewarticle/919500